673 / 1708
COG relative
Dose reduct.
COG
absolute
Dose reduct.
V5 Volume
CCSS
V5
COG
Mean dose reduction
at OAR Influence
Volume vs dose
breast
70.0%
11.6 Gy
59%
28% 27% smaller volume
heart
55.1%
17.4 Gy
99%
75% 9% smaller volume
lung
51.0%
11.1 Gy
2% smaller volume
thyroid 47.2%
19.0 Gy
Dose reduction
Advanced Stages of Hodgkin`s disease
Advanced stage do not profit as much as early stages from
Volume reduction Extended field vs Involved -side